Signal Transduction and Targeted Therapy

译名:信号转导与靶向治疗

SCIEJCR Q1中科院1区

>15

2026

影响因子区间

平台估算

投稿周期

63%

2025

中国作者发文占比

1700 USD

费用说明

收费

期刊简介:Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.

【译文】信号传导与靶向治疗(在线ISSN 2059-3635,印刷ISSN 2095-9907,CN 51-1758/R)是一本新的开放获取期刊,旨在及时发布与信号传导和靶向治疗相关的基础科学和临床研究方面的最新发现和进展。它将包括对主要人类疾病的研究,包括但不限于:癌症、心血管疾病、自身免疫性疾病和神经系统疾病。

出版社
Springer Nature
语言
English
学科
医学
ISSN
2059-3635
eISSN
2095-9907
出版频率
年刊
创刊年份
2016
投稿网址
http://mts-sigtrans.nature.com/
最近更新
2026-04-02 18:16:40
Signal Transduction and Targeted Therapy

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区1区
暂无
影响因子区间>15
暂无